Insulet (PODD) Tops Q3 EPS by 3c, Revenues Beat; Offers FY18 Revenue Outlook Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Insulet (PODD) Tops Q3 EPS by 3c, Revenues Beat; Offers FY18 Revenue Outlook Above Consensus

Insulet Reports Third Quarter 2018 Revenue of $151.1 Million, Up 24% Year-Over-Year, and Gross Margin Over 67%, Up 700 Basis Points

November 1, 2018 4:01 PM EDT

Achieved Both Positive Operating and Net Income for the First Time in Insulet's History

BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced financial results for the three months ended September 30, 2018.

Third Quarter Financial Highlights:

Third... More